Chemotherapy
Approved for: SCLC

Topotecan Hydrochloride (Hycamtin) is a FDA-approved Chemotherapy for small cell lung cancer (SCLC) in patients whose disease has not gotten better with other chemotherapy.

Related Research News

Pre- and Post-surgical Immunotherapy-based Treatment Significantly Improved Lung Cancer Outcomes

Pre- and Post-surgical Immunotherapy-based Treatment Significantly Improved Lung Cancer Outcomes

Long-term study reveals ‘ever-changing’ nature of lung cancer

Long-term study reveals ‘ever-changing’ nature of lung cancer

Lung Cancer Trial Has Broader Eligibility Criteria, Overcomes Barriers

Lung Cancer Trial Has Broader Eligibility Criteria, Overcomes Barriers